| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $1,423,277 ) |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | K99CA266947 | Spontaneous humoral responses open opportunities for novel immunotherapies against human cancer | 000 | 2 | NIH | 11/16/2022 | $108,422 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R03CA259873 | A framework to integrate live-cell imaging with single-cell sequencing and learn how cells adapt to new environments | 000 | 2 | NIH | 12/2/2022 | $81,686 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA227073 | Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers | 000 | 6 | NIH | 11/17/2022 | $642,902 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA231952 | Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers | 000 | 5 | NIH | 12/1/2022 | $541,196 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA223823 | Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer | 000 | 6 | NIH | 11/21/2022 | $656,535 |
| | 2023 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | P30CA076292 | Moffitt Cancer Center Support GrantDeterminants of Cancer Survivorship Among People Living with HIV (HIV/AIDS/Aging Cancer) | 000 | 24 | NIH | 10/19/2022 | $0 |
| | 2023 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | K99CA270423 | Targeting antioxidant vulnerabilities in KEAP1/NRF2 mutant NSCLC | 000 | 1 | NIH | 11/21/2022 | $0 |
| | 2023 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | CE145995 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/7/2022 | $0 |
| | 2023 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01DE030508 | Decoding tobacco-related oral cancer ecosystem by integrative approach | 000 | 2 | NIH | 11/22/2022 | -$571,277 |
| | 2023 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R00CA218686 | Vitamin B12 supplementation as novel therapeutic strategy to improve cancer-associated outcomes | 000 | 4 | NIH | 10/26/2022 | $0 |
| | 2023 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | U01CA244100 | Predict radiation-induced shifts in patient-specific tumor immune ecosystem composition to harness immunological consequences of radiotherapy | 000 | 3 | NIH | 12/6/2022 | $0 |
| | 2023 | 2020 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA234519 | Epigenetic Regulation of Drug Resistance to ABT-199 in B-cell Malignancies | 000 | 2 | NIH | 10/17/2022 | -$14,143 |
| | 2023 | 2020 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | U01CA202958 | Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer | 000 | 5 | NIH | 11/16/2022 | -$22,044 |
|
| Issue Date FY: 2022 ( Subtotal = $56,997,925 ) (Continued on the next page) |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R00CA218686 | Vitamin B12 supplementation as novel therapeutic strategy to improve cancer-associated outcomes | 000 | 4 | NIH | 3/11/2022 | $168,500 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R35GM142577 | New reagents for C-C and C-N bond formation | 001 | 2 | NIH | 6/22/2022 | $41,175 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R35GM142577 | New reagents for C-C and C-N bond formation | 000 | 2 | NIH | 4/8/2022 | $370,575 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA263911 | Developing mathematical model driven optimized recurrent glioblastoma therapies | 001 | 2 | NIH | 7/28/2022 | $188,644 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | P01CA250984 | Identifying Metabolic Vulnerabilities in Lung Cancer | 000 | 2 | NIH | 8/4/2022 | $2,029,016 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA262530 | Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers | 001 | 1 | NIH | 9/13/2022 | $29,208 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA262530 | Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers | 002 | 2 | NIH | 9/15/2022 | $74,145 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA262530 | Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers | 000 | 2 | NIH | 8/17/2022 | $666,846 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA249689 | CARES-REACH (Colorectal Cancer Awareness, Research, Education and Screening-Rural Expansion, Access and Capacity for Health) | 004 | 3 | NIH | 9/9/2022 | $68,055 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA249689 | CARES-REACH (Colorectal Cancer Awareness, Research, Education and Screening-Rural Expansion, Access and Capacity for Health) | 003 | 3 | NIH | 4/1/2022 | $207,977 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA249689 | CARES-REACH (Colorectal Cancer Awareness, Research, Education and Screening-Rural Expansion, Access and Capacity for Health) | 002 | 3 | NIH | 3/31/2022 | $613,483 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01HL151579 | Targeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms | 002 | 2 | NIH | 6/8/2022 | $48,329 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01HL151579 | Targeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms | 001 | 2 | NIH | 2/17/2022 | -$1 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01HL151579 | Targeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms | 000 | 2 | NIH | 2/2/2022 | $434,933 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA252373 | RESISTANCE AND RESPONSE SIGNALING TO PARP1 INHIBITORS IN OVARIAN CANCER | 001 | 2 | NIH | 7/7/2022 | $15,401 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA252373 | RESISTANCE AND RESPONSE SIGNALING TO PARP1 INHIBITORS IN OVARIAN CANCER | 000 | 2 | NIH | 1/4/2022 | $173,243 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01DK125367 | Improving weight loss outcomes of black women using a culturally relevant, stress management enhancement behavioral weight loss intervention | 000 | 3 | NIH | 4/28/2022 | $648,070 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA250018 | Functional characterization of prostate cancer risk loci by high throughput sequencing | 000 | 3 | NIH | 7/5/2022 | $366,164 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA239219 | Imaging Acidosis and Immune Therapy in PDAC | 002 | 3 | NIH | 8/26/2022 | $0 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA239219 | Imaging Acidosis and Immune Therapy in PDAC | 001 | 3 | NIH | 6/23/2022 | $54,677 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA239219 | Imaging Acidosis and Immune Therapy in PDAC | 000 | 3 | NIH | 1/13/2022 | $615,155 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | T32CA233399 | Integrated Program in Cancer and Data Science | 000 | 4 | NIH | 8/26/2022 | $441,104 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA230610 | Regulation of dendritic cell function and tumor immunity by TIM-3 | 000 | 4 | NIH | 8/4/2022 | $393,450 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA243552 | Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV | 000 | 4 | NIH | 8/30/2022 | $106,391 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | U01CA244100 | Predict radiation-induced shifts in patient-specific tumor immune ecosystem composition to harness immunological consequences of radiotherapy | 002 | 3 | NIH | 9/8/2022 | $168,500 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | U01CA244100 | Predict radiation-induced shifts in patient-specific tumor immune ecosystem composition to harness immunological consequences of radiotherapy | 001 | 3 | NIH | 5/13/2022 | $39,678 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | U01CA244100 | Predict radiation-induced shifts in patient-specific tumor immune ecosystem composition to harness immunological consequences of radiotherapy | 000 | 3 | NIH | 3/10/2022 | $275,960 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | T32CA090314 | Behavioral Oncology Education & Career Development | 000 | 19 | NIH | 8/4/2022 | $322,699 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | UH3CA202970 | Validation of EGFR Protein Complexes as Molecular Diagnostics | 000 | 5 | NIH | 6/30/2022 | $137,649 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | K08CA231454 | Finding Synergy with Radiation Therapy and Immunotherapy for Patients with Lung Cancer | 001 | 4 | NIH | 7/27/2022 | $238,752 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA240434 | Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma | 000 | 4 | NIH | 7/21/2022 | $537,558 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R37CA234021 | Developing and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia | 000 | 4 | NIH | 7/31/2022 | $496,638 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA241559 | Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation | 000 | 4 | NIH | 6/27/2022 | $385,581 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA250514 | Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells | 003 | 4 | NIH | 6/13/2022 | $30,141 |
| | 2022 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | K08CA237627 | Tumor suppressor roles of TFEB in the development and maintenance of myeloid leukemia | 000 | 4 | NIH | 8/1/2022 | $238,752 |
|
